Showing posts with label Ebix. Show all posts
Showing posts with label Ebix. Show all posts

Tuesday, May 10, 2011

Ebix ( Nasdaq - EBIX ) -- Q1 Results on Target

Ebix (EBIX $20.00) reported excellent on target Q1 results.  Excluding non-recurring acquisition costs, fully taxed earnings rose 43% to $.40 a share.  Revenues climbed 27% to $40.0 million.  The ADAM health insurance benefits acquisition contributed $4.2 million to revenue.  That deal was completed in mid February.  Backing that out, revenues improved at a 13% clip.  Ebix is the leading provider of computer based insurance exchanges that match customers with carriers through a network of brokers.  The system allows buyers to compare offers from multiple insurance companies in a convenient format.  While pricing is more competitive the carriers also benefit, from reduced marketing costs.  The direct computer hook-ups also facilitate compliance, since incorrect information can't be submitted.  Paper based exchanges often go back and forth several times.  Ebix's business is expanding due to the technology's productivity advantages.  Much of the insurance industry remains set its ways, though, so the company still has penetrated only a sliver of the potential market.  Overall insurance sales are lackluster because of the economy.  That's put a lid on same store growth, as well.

The ADAM acquisition moved Ebix into the employee benefits area.  ADAM's medical database offerings rank at the pinnacle of the industry.  But that operation always had trouble capitalizing on its potential due to below average technology management.  Software offerings usually were a generation behind.  Ebix already is improving those systems.  An initial upgrade is slated for introduction in the fall, when most companies open their benefit enrollment season.  Further enhancements promise to reinforce the trend in subsequent years.  Ebix plans to ultimately extend its reach beyond medical insurance into claims processing, to help carriers and hospitals automate the reimbursement process.  Most hospitals and insurance companies currently bolt on a variety of software packages, which can lead to incompatibility and wrong calculations.

We are raising our earnings estimate a nickel to $1.45 a share.  Our revenue estimate is unchanged at $175 million.  Growth could be sustained at superior levels as the employee benefit line gains momentum, more brokers and insurance companies adopt online exchange systems, and the overall insurance industry recovers.  Internal growth of 10%-20% appears sustainable well into the decade.   (Please see "Accounting Notes" for an explanation of our adjustments to reported earnings.  Addbacks include $556,000 for stock options, $1.2 million for acquired intangible amortization, and $1.79 million in one time deal costs.  Our tax rate is 17.0% compared to 9.4% as reported under GAAP rules.  It excludes tax loss carryforward benefits.)

( Click on Table to Enlarge )


Thursday, March 17, 2011

Ebix ( Nasdaq - EBIX ) -- Follow-up Report

Ebix (EBIX $27.50) reported excellent on target Q4 results.  Revenues improved 12% to $35.1 million.  Adjusted earnings rose 14% to $.32 a share.  All of the improvement was generated internally.  Ebix completed a pair of large acquisitions in 2009 that bolstered comparisons in previous quarters.  Fourth quarter growth was largely organic.  Our income figure excludes non cash stock option expense ($1.85 million).  It also excludes tax loss carryforward benefits ($7.5 million).  Official earnings reported by the company were higher, as a result.  Aided by the acquisitions, full year revenues climbed 35% to $132.2 million.  Earnings jumped 29% to $1.19 a share.  Organic growth for the year equalled 11%.

The ADAM acquisition in February will open up the health insurance market to Ebix's exchange technology.  That transaction was paid for primarily with stock, moderating the immediate earnings leverage.  The new line promises to lift 2011 income by $.10 a share or more, nonetheless.  ADAM is well established in the small business market.  Ebix plans to enhance the technology to improve performance and lower costs, making its exchange more attractive to policy providers and business customers alike.  The technology also should attract additional brokers, reinforcing the momentum.  Longer term, volume could surge once the new national health insurance rules are implemented.

Meantime, Ebix is poised to sustain growth at superior levels.  We estimate 2011 sales will improve 10%-15% internally.  Combined with the ADAM contribution, revenues could reach $175 million.  Earnings likely will expand at a slower pace due to the additional shares issued to purchase ADAM.  Still, an 18% gain to $1.40 a share appears obtainable.  Further acquisitions are possible.  An in-house expansion into the property and casualty insurance exchange market is slated for this year, laying the groundwork for additional leverage in the future.

( Click on Table to Enlarge )

Friday, November 12, 2010

Ebix ( Nasdaq - EBIX )

Ebix (EBIX $22.00) is the leading provider of annuity and policy exchange systems for the insurance industry.  The company's on demand software allows brokers and agents to download competing bids, compare them by features and pricing, and automatically prepare the paperwork once a decision is made.  The technology makes it easier to analyze different products from competing underwriters.  In the past agents and clients were required to wade through mounds of paper that didn't lend itself to direct comparison.  The systems also produce 100% correct data for the winning insurance carrier.  The order can't be submitted unless the information is filled out correctly.  Using paper based systems, agents usually have to re-file the material several times.  The computerized exchange format gives annuity and insurance buyers greater selection and transparency, often at a lower cost.  Insurance companies enjoy cost savings, as well, plus they gain the opportunity to address a broader potential market.  Agents and brokers are able to process transactions more rapidly and with fewer errors, reducing their costs; plus customer satisfaction is higher due to the greater selection, transparency, and ease of use.

The automated exchange business accounts for 71% of revenues.  Ebix also sells office management software to insurance brokers (10%), back-end systems for insurance carriers to track policy claims and manage day to day operations (7%), and business process outsourcing ("BPO") services to automate the issuance and tracking of insurance certificates (12%).  Exchange revenues are based on the volume of data that goes through the system, and is recurring in nature.   The BPO work tends to be consistent, as well.  Sales of software products to brokers and insurance companies often lead to exchange and outsourcing business but aren't recurring themselves.  The United States accounts for 75% of sales.  Australia until recently generated most of the rest.  An acquisition in Q3 laid the groundwork for expansion into Brazil, which could become a significant contributor in upcoming periods.

Growth has been explosive.  Organic gains of 15% have been achieved over the past several years.  Acquisitions have provided further impetus.  Ebix recently announced plans to merge with ADAM, a major provider of software in the employee benefits area.  That company has struggled over the years to streamline the software required to run the operation.  Those battles also prevented ADAM from expanding into new areas.  The name of the game at Ebix is high performance software development at a low cost (India).  Once ADAM is in the fold, expected by year end, significant improvement is likely.  ADAM currently generates about $30 million a year in revenues.

Meantime, Ebix is enjoying another great year.  Revenues are poised to climb 33% to $130 million.  Earnings could advance 25% to $1.15 a share despite sharply higher levels of spending on product development and marketing.  (See "Accounting Notes.")  Next year, assuming ADAM is consolidated for the entire year, we estimate revenues will increase 35% to $175 million to support income of $1.40 a share (+22%).  The company is acquiring ADAM in an all stock transaction, so shares outstanding will rise about 10%.  Growth could be maintained at superior levels well into the decade.  Electronic insurance exchanges remain in an early stage of development.  Only 20%-25% of annuity contracts are bid that way in the U.S., while car, home, health, and life insurance remain below 5% penetration.  Foreign expansion promises additional opportunities.  Organic growth has moderated to the 10% range during the last year as a result of the recession.  But higher levels are likely once the insurance market rebounds.  Bolstered by low cost but complementary acquisitions, earnings could reach $2.25 a share within 2-3 years on revenues of $275 million.  Applying a P/E multiple of 20x suggests a target price of $45 a share, potential appreciation of 100% from the current quote.

(Click on table to enlarge)